|
1
|
Vavalle JP, van Diepen S, Clare RM,
Hochman JS, Weaver WD, Mehta RH, Pieper KS, Patel MR, Patel UD,
Armstrong PW, et al: Renal failure in patients with ST-segment
elevation acute myocardial infarction treated with primary
percutaneous coronary intervention: Predictors, clinical and
angiographic features, and outcomes. Am Heart J. 173:57–66. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Husebye T, Eritsland J, Müller C, Sandvik
L, Arnesen H, Seljeflot I, Mangschau A, Bjørnerheim R and Andersen
GØ: Levosimendan in acute heart failure following primary
percutaneous coronary intervention-treated acute ST-elevation
myocardial infarction. Results from the LEAF trial: A randomized,
placebo-controlled study. Eur J Heart Fail. 15:565–572. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Herrmann J, Gersh BJ, Goldfinger JZ,
Witzenbichler B, Guagliumi G, Dudek D, Kornowski R, Brener SJ,
Parise H, Fahy M, et al: Body mass index and acute and long-term
outcomes after acute myocardial infarction (from the harmonizing
outcomes with revascularization and stents in acute myocardial
infarction trial). Am J Cardiol. 114:9–16. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang ZF, Wang NP, Harmouche S, Philip T,
Pang XF, Bai F and Zhao ZQ: Postconditioning promotes the cardiac
repair through balancing collagen degradation and synthesis after
myocardial infarction in rats. Basic Res Cardiol. 108:3182013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang CC, Wei HJ, Lin KJ, Lin WW, Wang CW,
Pan WY, Hwang SM, Chang Y and Sung HW: Multimodality noninvasive
imaging for assessing therapeutic effects of exogenously
transplanted cell aggregates capable of angiogenesis on acute
myocardial infarction. Biomaterials. 73:12–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang YJ, Yang SH, Li MH, Iqbal J,
Bourantas CV, Mi QY, Yu YH, Li JJ, Zhao SL, Tian NL and Chen SL:
Berberine attenuates adverse left ventricular remodeling and
cardiac dysfunction after acute myocardial infarction in rats: role
of autophagy. Clin Exp Pharmacol Physiol. 41:995–1002. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fraccarollo D, Galuppo P, Neuser J,
Bauersachs J and Widder JD: Pentaerythritol tetranitrate targeting
myocardial reactive oxygen species production improves left
ventricular remodeling and function in rats with ischemic heart
failure. Hypertension. 66:978–987. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nedoboy PE, Morgan PE, Mocatta TJ,
Richards AM, Winterbourn CC and Davies MJ: High plasma thiocyanate
levels are associated with enhanced myeloperoxidase-induced thiol
oxidation and long-term survival in subjects following a first
myocardial infarction. Free Radic Res. 48:1256–1266. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang X, Qin Y, Shao S, Yu Y, Zhang C, Dong
H, Lv G and Dong S: MicroRNA-214 inhibits left ventricular
remodeling in an acute myocardial infarction rat model by
suppressing cellular apoptosis via the phosphatase and tensin
homolog (PTEN). Int Heart J. 57:247–250. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xue R, Lei S, Xia ZY, Wu Y, Meng Q, Zhan
L, Su W, Liu H, Xu J, Liu Z, et al: Selective inhibition of PTEN
preserves ischaemic post-conditioning cardioprotection in
STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and
JAK2/STAT3 pathways. Clin Sci (Lond). 130:377–392. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Parajuli N, Yuan Y, Zheng X, Bedja D and
Cai ZP: Phosphatase PTEN is critically involved in post-myocardial
infarction remodeling through the Akt/interleukin-10 signaling
pathway. Basic Res Cardiol. 107:2482012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boon RA and Dimmeler S: MicroRNAs in
myocardial infarction. Nat Rev Cardiol. 12:135–142. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi H, Zhang G, Wang J, Wang Z, Liu X,
Cheng L and Li W: Studying dynamic features in myocardial
infarction progression by integrating miRNA-transcription factor
co-regulatory networks and time-series RNA expression data from
peripheral blood mononuclear cells. PLoS One. 11:e01586382016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yano H, Hibi K, Nozawa N, Ozaki H, Kusama
I, Ebina T, Kosuge M, Tsukahara K, Okuda J, Morita S, et al:
Effects of valsartan, an angiotensin II receptor blocker, on
coronary atherosclerosis in patients with acute myocardial
infarction who receive an angiotensin-converting enzyme inhibitor.
Circ J. 76:1442–1451. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Räber L, Kelbæk H, Taniwaki M, Ostojic M,
Heg D, Baumbach A, von Birgelen C, Roffi M, Tüller D, Engstrøm T,
et al: Biolimus-eluting stents with biodegradable polymer versus
bare-metal stents in acute myocardial infarction: Two-year clinical
results of the COMFORTABLE AMI trial. Circ Cardiovasc Interv.
7:355–364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Y, Chen JY, Huo Y, Ge JB, Xian Y, Duan
CY, Chen SQ, Jiang W, Chen PY and Tan N: RESCIND group: Aggressive
hydraTion in patients with ST-Elevation Myocardial infarction
undergoing Primary percutaneous coronary intervention to prevenT
contrast-induced nephropathy (ATTEMPT): Study design and protocol
for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First
study for REduction of contraSt-induCed nephropathy followINg
carDiac catheterization) trial. Am Heart J. 172:88–95. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hofsten DE, Kelbaek H, Helqvist S,
Kløvgaard L, Holmvang L, Clemmensen P, Torp-Pedersen C, Tilsted HH,
Bøtker HE, Jensen LO, et al: The third DANish study of optimal
acute treatment of patients with ST-segment Elevation Myocardial
infarction: Ischemic postconditioning or deferred stent
implantation versus conventional primary angioplasty and complete
revascularization versus treatment of culprit lesion only:
Rationale and design of the DANAMI 3 trial program. Am Heart J.
169:613–621. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bronze-da-Rocha E: MicroRNAs expression
profiles in cardiovascular diseases. Biomed Res Int.
2014:9854082014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matsumoto S, Sakata Y, Nakatani D, Suna S,
Mizuno H, Shimizu M, Usami M, Sasaki T, Sato HKawahara Y, et al: A
subset of circulating microRNAs are predictive for cardiac death
after discharge for acute myocardial infarction. Biochem Biophys
Res Commun. 427:280–284. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mao J, Lv Z and Zhuang Y: MicroRNA-23a is
involved in tumor necrosis factor-alpha induced apoptosis in
mesenchymal stem cells and myocardial infarction. Exp Mol Pathol.
97:23–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim SJ, Kuklov A and Crystal GJ: In vivo
gene delivery of XIAP protects against myocardial apoptosis and
infarction following ischemia/reperfusion in conscious rabbits.
Life Sci. 88:572–577. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mei B, Wang T, Wang Y, Xia Z, Irwin MG and
Wong GT: High dose remifentanil increases myocardial oxidative
stress and compromises remifentanil infarct-sparing effects in
rats. Eur J Pharmacol. 718:484–492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hazini A, Cemek M, Isildak I, Alpdağtaş S,
Önül A, Şenel Ü, Kocaman T, Dur A, Iraz M and Uyarel H:
Investigation of ischemia modified albumin, oxidant and antioxidant
markers in acute myocardial infarction. Postepy Kardiol
Interwencyjnej. 11:298–303. 2015.PubMed/NCBI
|
|
25
|
Zhao H, Tao Z, Wang R, Liu P, Yan F, Li J,
Zhang C, Ji X and Luo Y: MicroRNA-23a-3p attenuates oxidative
stress injury in a mouse model of focal cerebral
ischemia-reperfusion. Brain Res. 1592:65–72. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li R, Geng HH, Xiao J, Qin XT, Wang F,
Xing JH, Xia YF, Mao Y, Liang JW and Ji XP: miR-7a/b attenuates
post-myocardial infarction remodeling and protects H9c2
cardiomyoblast against hypoxia-induced apoptosis involving Sp1 and
PARP-1. Sci Rep. 6:290822016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ham O, Lee SY, Lee CY, Park JH, Lee J, Seo
HH, Cha MJ, Choi E, Kim S and Hwang KC: let-7b suppresses apoptosis
and autophagy of human mesenchymal stem cells transplanted into
ischemia/reperfusion injured heart 7by targeting caspase-3. Stem
Cell Res Ther. 6:1472015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Agosto M, Azrin M, Singh K, Jaffe AS and
Liang BT: Serum caspase-3 p17 fragment is elevated in patients with
ST-segment elevation myocardial infarction: A novel observation. J
Am Coll Cardiol. 57:220–221. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Luo KQ, Long HB and Xu BC: Reduced
apoptosis after acute myocardial infarction by simvastatin. Cell
Biochem Biophys. 71:735–740. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Boyle AJ, Hwang J, Ye J, Shih H, Jun K,
Zhang Y, Fang Q, Sievers R, Yeghiazarians Y and Lee RJ: The effects
of aging on apoptosis following myocardial infarction. Cardiovasc
Ther. 31:e102–e110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang N, Zhu M, Wang X, Tan HY, Tsao SW and
Feng Y: Berberine-induced tumor suppressor p53 up-regulation gets
involved in the regulatory network of MIR-23a in hepatocellular
carcinoma. Biochim Biophys Acta. 1839:849–857. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang C, Li Q, Wang W, Guo L, Guo C, Sun Y
and Zhang J: GLP-1 contributes to increases in PGC-1α expression by
downregulating miR-23a to reduce apoptosis. Biochem Biophys Res
Commun. 466:33–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tian K, Di R and Wang L: MicroRNA-23a
enhances migration and invasion through PTEN in osteosarcoma.
Cancer Gene Ther. 22:351–359. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li CM, Shen SW, Wang T and Zhang XH:
Myocardial ischemic post-conditioning attenuates ischemia
reperfusion injury via PTEN/Akt signal pathway. Int J Clin Exp Med.
8:15801–15807. 2015.PubMed/NCBI
|
|
35
|
Keyes KT, Xu J, Long B, Zhang C, Hu Z and
Ye Y: Pharmacological inhibition of PTEN limits myocardial infarct
size and improves left ventricular function postinfarction. Am J
Physiol Heart Circ Physiol. 298:H1198–H1208. 2010. View Article : Google Scholar : PubMed/NCBI
|
